Stablecoin Development Corporation: A Pharmaceutical Company's Pivot into the Digital Asset Space

NovaBay Pharmaceuticals has exited its biopharmaceutical business and rebranded as Stablecoin Development Corporation, with a focus on the stablecoin economy. The company holds approximately 2.06 billion SKY tokens, valued at $144-$147 million, acquired through a private placement and open market purchases. Stablecoin Development Corporation aims to become a premier public vehicle for accessing cash flows from the stablecoin economy, specifically through the yield-bearing USDS stablecoin.